S. Paganoni

TDP-43 loss induces cryptic polyadenylation in ALS/FTD
20258 citationsauthor #61
Cervical Collar Satisfaction and Functional Impact in Amyotrophic Lateral Sclerosis: A Survey Study.
20252 citationsauthor #10
Access for ALL in ALS: A large‐scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis
20247 citationsauthor #2
The cycad genotoxin methylazoxymethanol, linked to Guam ALS/PDC, induces transcriptional mutagenesis
202410 citationsauthor #54
Author Correction: TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
20242 citationsauthor #61
A framework for sharing of clinical and genetic data for precision medicine applications
202422 citationsauthor #48
Occupational Characteristics Associated with Professional Fulfillment and Burnout Among U.S. Physiatrists
20231 citationsauthor #3
Restoring arm function with a soft robotic wearable for individuals with amyotrophic lateral sclerosis
202376 citationsauthor #9
Association of Polyunsaturated Fatty Acids and Clinical Progression in Patients With ALS
202315 citationsauthor #4
Effect of sodium phenylbutyrate and taurursodiol on plasma concentrations of neuroinflammatory biomarkers in amyotrophic lateral sclerosis: results from the CENTAUR trial
202313 citationsauthor #7
Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score–Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database (S33.005)
20230 citationsauthor #1
Occupational Characteristics Associated With Professional Fulfillment and Burnout Among US Physiatrists
20239 citationsauthor #3
Results from the first four regimens of the HEALEY ALS Platform Trial (PL5.004)
20231 citationsauthor #1
Evidence for Survival Benefit in ALS with CNM-Au8 Treatment Across Three Study Populations (P8-8.004)
20230 citationsauthor #3
High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial
202329 citationsauthor #12
Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls
202313 citationsauthor #1
Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosis
202310 citationsauthor #28
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)
20236 citationsauthor #28
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis
202333 citationsauthor #14
Ultrasound-guided glenohumeral joint injections for shoulder pain in ALS: A case series
20231 citationsauthor #14
Statin medications and amyotrophic lateral sclerosis incidence and mortality.
20221 citationsauthor #4
Safety and activity of anti‐CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol
202217 citationsauthor #33
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
202268 citationsauthor #7
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
2022353 citationsauthor #61
P.049 Determining individual substantial response in amyotrophic lateral sclerosis: utilizing a new method on CENTAUR trial results
20220 citationsauthor #5
An expanded access protocol of RT001 in amyotrophic lateral sclerosis—Initial experience with a lipid peroxidation inhibitor
202213 citationsauthor #27
Primary lateral sclerosis natural history study – planning, designing, and early enrollment
20227 citationsauthor #13
Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes
202239 citationsauthor #1
Environmental Impact of Telerehabilitation Visits in an Urban Setting
20226 citationsauthor #2
ALSUntangled #64: butyrates
20229 citationsauthor #16
Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS
202219 citationsauthor #12
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial
202221 citationsauthor #12
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
202258 citationsauthor #1
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
202240 citationsauthor #10
Theme 09 - CLINICAL TRIALS AND TRIAL DESIGN
20211 citationsauthor #26
Prediagnostic Neurofilament Light Chain Levels in Amyotrophic Lateral Sclerosis
202144 citationsauthor #6
Research and Industry Partnerships in Physiatry.
20212 citationsauthor #8
Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification Mechanism
20215 citationsauthor #6
The Impact of a Culinary Coaching Telemedicine Program on Home Cooking and Emotional Well-Being during the COVID-19 Pandemic
202127 citationsauthor #7
Incidence of and Mortality From Amyotrophic Lateral Sclerosis in National Football League Athletes
202153 citationsauthor #9
ALS (Amyotrophic Lateral Sclerosis) Patient Recruitment for Clinical Trials and Epidemiological Studies: National ALS Registry’s Research Notification Mechanism (Preprint)
20218 citationsauthor #6
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale
202120 citationsauthor #5
Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial
202131 citationsauthor #13
Using Smartphones to Reduce Research Burden in a Neurodegenerative Population and Assessing Participant Adherence: A Randomized Clinical Trial and Two Observational Studies
202117 citationsauthor #5
Comparison of Two Clinical Upper Motor Neuron Burden Rating Scales in ALS Using Quantitative Brain Imaging.
202112 citationsauthor #8
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development
202169 citationsauthor #1
P.059 Results From the Randomized and Open-Label Periods of the CENTAUR Trial of Sodium Phenylbutyrate and Ursodoxicoltaurine in Amyotrophic Lateral Sclerosis (ALS)
20210 citationsauthor #1
Impact of the National Amyotrophic Lateral Sclerosis (ALS) Registry's Research Notification Mechanism (RNM) on Patient Recruitment for Clinical Trials and Epidemiological Studies (Preprint)
20210 citationsauthor #6
Evidence-Based Medicine Training in United States–Based Physiatry Residency Programs
20212 citationsauthor #22
Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic
202111 citationsauthor #3
Improving Grasp Function After Spinal Cord Injury With a Soft Robotic Glove
202052 citationsauthor #8
Smartphone data during the COVID‐19 pandemic can quantify behavioral changes in people with ALS
202021 citationsauthor #7
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
202076 citationsauthor #419
Highest‐Ranking Articles by Altmetric Attention Scores in Three Rehabilitation Journals
20202 citationsauthor #6
Neurological Manifestation of COVID-19 and the Enhanced Role of Physiatrists
202010 citationsauthor #6
Imaging Neurochemistry and Brain Structure Tracks Clinical Decline and Mechanisms of ALS in Patients
202022 citationsauthor #13
Improved function in a runner with hereditary spastic paraparesis with use of extracorporeal shockwave therapy: personal clinical experience.
20201 citationsauthor #2
Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis
202020 citationsauthor #8
Preface: promoting research in PLS: current knowledge and future challenges
20207 citationsauthor #54
Evidence-Based Physiatry: Efficacy of Home-Based Telerehabilitation vs In-Clinic Therapy for Adults After Stroke.
202015 citationsauthor #6
Clinical care and therapeutic trials in PLS
20206 citationsauthor #5
Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis
202020 citationsauthor #12
Amyotrophic lateral sclerosis care and research in the United States during the COVID‐19 pandemic: Challenges and opportunities
202052 citationsauthor #10
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
2020101 citationsauthor #5
The NEALS primary lateral sclerosis registry
202015 citationsauthor #1
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
2020368 citationsauthor #1
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures
202058 citationsauthor #24
Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis
2020137 citationsauthor #1
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
202047 citationsauthor #46
Exploring the use of educational materials for increasing participation in a stretching program: a quality improvement project in people with motor neuron disease.
20203 citationsauthor #15
Ultra-high field (7T) functional magnetic resonance imaging in amyotrophic lateral sclerosis: a pilot study
202014 citationsauthor #8
Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale
201928 citationsauthor #6
All-Cause and Cause-Specific Mortality Among Major League Baseball Players.
20195 citationsauthor #4
Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis
201933 citationsauthor #11
Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: Observations from one center
201936 citationsauthor #2
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia
2019259 citationsauthor #58
Design and results of a smartphone‐based digital phenotyping study to quantify ALS progression
201981 citationsauthor #2
Telemedicine to innovate amyotrophic lateral sclerosis multidisciplinary care: The time has come
201924 citationsauthor #1
Cooking Online With a Chef: Health Professionals’ Evaluation of a Live Culinary Coaching Module
201915 citationsauthor #3
Use of Beiwe Smartphone App to Identify and Track Speech Decline in Amyotrophic Lateral Sclerosis (ALS)
201922 citationsauthor #3
Reply to Letter to the Editor regarding Paganoni S: Evidence-based physiatry; managing low back pain wisely. Am J Phys Med Rehabil 2018;97: 85.
20190 citationsauthor #1
The 'Nuts 'n Bolts' of Evidence-Based Physiatry (EBP): Core Competencies for trainees and clinicians.
20192 citationsauthor #2
Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis
201937 citationsauthor #14
Measuring the Impact of Research Using Conventional and Alternative Metrics
201922 citationsauthor #2
Soft Robotic Glove with Integrated Sensing for Intuitive Grasping Assistance Post Spinal Cord Injury
201947 citationsauthor #10
Case 12-2019: A 60-Year-Old Man with Weakness and Difficulty Chewing.
20190 citationsauthor #3
Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis
201927 citationsauthor #1
Cochrane Corners to Enhance Access to Evidence-Based Physiatry (EBP)
20181 citationsauthor #1
Experience with telemedicine in a multi-disciplinary ALS clinic
201842 citationsauthor #2
Evidence-Based Physiatry: Managing Low Back Pain Wisely.
20182 citationsauthor #1
Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS‐linked SOD1G93A mutant mice
201822 citationsauthor #6
Evidence-Based Physiatry: Key Role of Rehabilitation in New CDC Guidelines for the Management of Duchenne Muscular Dystrophy.
20181 citationsauthor #1
A pilot trial of RNS60 in amyotrophic lateral sclerosis
201829 citationsauthor #1
Assisting hand function after spinal cord injury with a fabric-based soft robotic glove
2018234 citationsauthor #8
Evidence-Based Physiatry (EBP).
20182 citationsauthor #1
Autoimmune disease preceding amyotrophic lateral sclerosis
201827 citationsauthor #1
Integrated MRI and [11C]-PBR28 PET Imaging to Characterize In vivo Glial Activation in Amyotrophic and Primary Lateral Sclerosis: Cross Sectional and Longitudinal Study (P2.032)
20180 citationsauthor #13
Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis
201810 citationsauthor #10
Evidence-Based Physiatry: Clinical Practice Guideline: Noninvasive Treatments for Low Back Pain.
20182 citationsauthor #1
Integrated magnetic resonance imaging and [11C]‐PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis
201887 citationsauthor #13

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT